Framework for the evaluation of new tests for tuberculosis infection

Yohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, Adam Penn-Nicholson, Morten Ruhwald, Dick Menzies, Olivia Oxlade, Dennis Falzon, Avinash Kanchar, Alexei Korobitsyn, Matteo Zignol, Alberto Matteelli, Tereza Kasaeva

Source: Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020
Journal Issue: August
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, Adam Penn-Nicholson, Morten Ruhwald, Dick Menzies, Olivia Oxlade, Dennis Falzon, Avinash Kanchar, Alexei Korobitsyn, Matteo Zignol, Alberto Matteelli, Tereza Kasaeva. Framework for the evaluation of new tests for tuberculosis infection. Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease
Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018
Year: 2018



Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008

Evaluation of non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis: Interim analysis of a TBNET study
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012


HIV infection and diagnostic tests for pleural tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 360s
Year: 2001

Characteristics of the new cases of the tuberculosis according to the method of screening
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Evaluation of new biomarkers for laboratory diagnosis of tuberculosis
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Using results of new laboratory test for tuberculosis infection in children
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


The diagnosis of latent tuberculosis infection in children with new immunologic tests
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013


Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Performance of blood tests for the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008

Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006

Monitoring latent tuberculosis infection diagnosis and management in the Netherlands
Source: Eur Respir J 2016; 47:1492-1501
Year: 2016



Evaluation of a tuberculosis control programme based on case-finding
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012


Tests for tuberculosis infection: landscape analysis
Source: Eur Respir J, 58 (5) 2100167; 10.1183/13993003.00167-2021
Year: 2021



New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019


IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


Cost-effectiveness of two latent tuberculosis infection screening strategies
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018




Ability of genotypical method to make assesment of tuberculosis infection hotbed
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015